abstract |
The invention relates to a pharmaceutical composition comprising a first and a second polypeptide, being the alpha and beta chain of the Lactobacillus plantarum bacteriocin NC8 respectively, for use in the prevention or treatment of a periodontal disease. Wherein the first polypeptide has at least90%, 95%, 96%, 97%, 98% or 99% sequence identity (% SI) with SEQ ID 1 and, the secondpeptide has at least 90%, 95%, 96%, 97 %, 98% or 99% sequence identity (% SI) with SEQ ID 2. lnk. t. Patent and Government 2017 -07- Z I.E-mail |